Medijski sadržaj
- Tweetovi
- Tweetovi i odgovori
- Medijski sadržaj, trenutna stranica.
-
Proud to participate and sponsor Rare In the Square. Thanks to Global Genes and the other sponsors for bringing this important event to
#JPM2020#2020RITS#rareinthesquarepic.twitter.com/HdMTa7Mm5b
-
Cydan is excited to support Global Genes at the Rare in the Square event at
#JPM2020@Cydanco@GlobalGenespic.twitter.com/3cDquVHicS
-
We're proud to have attended the
@CureFA_org Energy Ball! Pictured here is Ronald J. Bartek, President/Director/Co-Founder of FARA, and James McArthur, Founder and President of Cydan.pic.twitter.com/NFB4ZAyoSm
-
We're excited to be participating in the Global Genes Rare Patient Advocacy Summit. If you're attending, swing by Imran's panel - Friday September 20 at 1:00pic.twitter.com/6ugLMTZOYM
-
James and Ryan had a great time this weekend at Cycle 4 CMT, a fundraising ride for Charcot-Marie-Tooth, or CMT. If you’re interested in helping, consider donating at https://cmta.akaraisin.com/pledge/Team/Home.aspx?seid=19065&mid=10&tid=237362&sgid= …pic.twitter.com/Vb0n8LXH7z
-
This Saturday we’ll be riding for a good cause and fundraising to find a cure for people with Charcot-Marie-Tooth, or CMT, a progressive neurological disease. If you’re interested in helping, consider donating at http://ow.ly/xaVS50vHdjk pic.twitter.com/QEIoJOtXvP
-
Cydan is excited to participate at the annual HNRNPH2 family meeting. Great scientific progress and increase in rate of patient identification => 100 patients soon!
#RareDisease#autismawareness http://ybrp.org pic.twitter.com/gd88YVOhl9
-
Our Co-Founder and President R&D, James McArthur, has been a part of the FARA board of directors and scientific advisory board for the last several years as part of our commitment to help advance meaningful treatments for patients with rare genetic diseases.pic.twitter.com/q1uVs6kBWj
-
If you're attending the
#RareDiseaseSummit today,#Cydan's Imran Babar, PhD, will be part of a panel discussion during the Partnering & Investment track at 1:45 p.m. Under its collaborative model, Cydan has launched three new companies focused on rare disease.pic.twitter.com/1ZdykFXWPg
-
#Cydan's Imran Babar, PhD will be in Boston at the#RareDiseaseSummit tomorrow to participate in a panel discussion on funding rare disease therapies. Cydan works with leading investors in#lifesciences to accelerate science to medicine. http://ow.ly/brFm50uBw8N pic.twitter.com/jWDnE6V5z1
-
Our team is wrapping up a great week at
#BIO2019. Thank you to@BIOConvention for connecting the best in the industry and helping#Cydan's efforts to uncover compelling new science and promising drug candidates in#raredisease. http://ow.ly/xuyC50uwCYv pic.twitter.com/w6YM8zHmtZ
-
We’re hoping to help a friend. Ranjana has been on dialysis and needs a new kidney. Despite her disease, she’s graduated both high school and college. Let’s help this fighter find a new kidney. Please spread the word.
#kidneydonation#organdonation https://www.nkr.org/FSG594 pic.twitter.com/biKaMKxKnB
-
#Cydan engages with academic and government laboratories, and small biotechnology and pharmaceutical companies worldwide to pinpoint opportunities in the development of new therapies for#rarediseases.#BIO2019 http://ow.ly/o93B50uwAAN pic.twitter.com/vsb5C7aK0E
-
Happy to be in Philadelphia to network with 17,000+ colleagues at
#BIO2019!#Cydan is a champion of rare disease therapies. Let's connect to talk about your scientific concept, program or asset!#raredisease http://ow.ly/VVIp50uvnBm pic.twitter.com/wD9STSJwTw
-
Cydan is deeply invested in improving the lives of patients with rare diseases like Friedreich's Ataxia. Check out our latest 'Rare Views' blog post to learn about our relationship with
@CureFA_org and our unique approach to patient care.#raredisease http://ow.ly/qXLy50ut7JF pic.twitter.com/y61BlVBiC7
-
Excited to support Entrepreneurship
@mit100k - 30 years getting better every year!#startuppic.twitter.com/rMZVpCifBL
-
We're at
#REACTcongress talking#raredisease#research this week. Our work starts with a compelling scientific idea or promising drug candidate from academia and industry. Pleased to make new connections and learn about exciting new research!pic.twitter.com/duljMLsrAE
-
This week,
#Cydan is at@react_community's RE(ACT) Congress America. We're invested in the advancement of rare and orphan disease research and are excited to make connections and immerse ourselves in cutting-edge research.#RAREvolution#rarediseasepic.twitter.com/MWpl9j1URh
-
The need for treatments for patients facing rare genetic diseases is astounding. Of the more than 7,000 rare diseases, there are only 400 treatments available. We can do better.
#raredisease http://ow.ly/cSMH30o8wfS pic.twitter.com/H1qdbEEVfR
-
De-risking, the final stage of our collaborative model, is designed to yield a pre-investigational new drug (IND) or IND-enabled asset considered ready for funding and to launch a new company to bring this orphan drug candidate to patients. http://ow.ly/VAfQ30nWOsx pic.twitter.com/7B2F7GUJOn
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.